Biotech Startups
9,920 companies tagged Biotech, with their investors and founders.
Interobio Systems develops stem-cell-derived human intestinal organoids that include functioning neurons, blood vessels, muscle, and intestinal lining for use in preclinical drug testing. The company applies human biology and organoid technology to support drug discovery and development.
2 investors
Intrommune is a biotechnology company developing oral mucosal immunotherapy (OMIT), which delivers allergenic proteins through a specially formulated toothpaste to treat peanut and other food allergies. Its products target patients and families managing food allergies, spanning early allergen introduction in at-risk children and treatment options for those living with food allergy.
2 investors
Invenra develops proprietary platform technologies to discover and develop novel bi- and multi-specific antibody therapies, with an initial focus on oncology. The company is advancing pipelines of antibody candidates with partners and intends to expand into additional disease categories.
2 investors
iOmx Therapeutics is a biotech company developing novel cancer therapies. Based in Munich's Martinsried biotech hub, the company focuses on transforming cancer treatment through scientific research and collaborative innovation.
2 investors
IONLACE develops modular protein design tools, combining AI models with a lab-in-the-loop experimental approach to design and engineer new molecules for medicine. The company builds biotech tools aimed at advancing human health and programmable biology.
2 investors
A clinical-stage biotech company developing novel targeted cancer therapies and immunomodulatory drugs with a global equity strategy. The company operates a translational medicine platform and focuses on solid tumors and drug-resistant cancers.
2 investors
IonPath develops MIBIscope, a spatial proteomics platform that uses multiplexed ion beam imaging to simultaneously measure dozens of protein targets in preserved tissue samples for translational research and discovery. The platform is used in oncology, immunology, and spatial biology studies across research institutions.
2 investors
ionSIGHT provides an AI-driven analytical platform using native mass spectrometry to analyze protein structure and interactions for drug discovery applications. The platform enables high-throughput structural biology and biophysics insights for pharmaceutical developers.
2 investors
iosBio develops oral, thermostable vaccine candidates using its ESD platform, with a lead program (OraPro-EBV) targeting Epstein-Barr Virus. The company operates in the biotechnology and vaccine development sector.
2 investors
2 investors
IQVIA is a healthcare data and technology company that supports life sciences organizations in research, clinical development, and commercialization of medicines and medical solutions.
2 investors
Irazú Oncology develops cancer immunotherapies using a proprietary Outer Membrane Vesicles (OMV) platform based on engineered bacterial nanoparticles that deliver cancer antigens. The biotech company, founded in 2022, is building a pipeline of immunotherapies for cancer patients.
2 investors
Iris Medicine is an early-stage biotech developing RNA therapies based on its small binding RNA (sbRNA) platform, which uses cooperative RNAi binding to selectively silence mutant genes carrying expanded pathologic repeat sequences while preserving healthy alleles. Its lead programs target repeat expansion disorders including Huntington's Disease, C9orf72 ALS, and the Spinocerebellar Ataxias.
2 investors
IVIDATA Life Sciences is a French consulting firm serving healthcare and life sciences players, supporting projects from clinical research through market launch. Its roughly 140 consultants work across three areas: biometrics and data, clinical operations and development, and regulatory affairs and vigilance, with a European focus.
2 investors
Jade Biosciences develops therapeutic antibodies targeting autoimmune diseases, with a lead candidate in clinical development for immunoglobulin A nephropathy, a chronic kidney disease. The company's pipeline includes additional candidates designed to modulate immune system responses in autoimmune conditions.
2 investors
Jasper Therapeutics develops briquilimab, a targeted anti-KIT monoclonal antibody designed to deplete mast cells for treating chronic immunological and inflammatory diseases. The company is running clinical studies in chronic spontaneous urticaria, chronic inducible urticaria, and allergic asthma.
2 investors
Jumpcode Genomics develops CRISPRclean, a next-generation sequencing technology that removes abundant, uninformative sequences to improve sensitivity, lower costs, and simplify workflows for researchers. Its technology is used in basic research, infectious disease, oncology, and consumer genomics.
2 investors
Juniper Genomics provides genomic testing for IVF, including enhanced PGT-A that analyzes both DNA and RNA from a single embryo biopsy to assess chromosome status and embryo viability, and PGT-G that expands analysis across nearly the full genome from the same sample. Its products serve fertility clinicians and IVF patients making embryo selection and genetic risk decisions.
2 investors
Jupiter is a biotech company that discovers and develops new medicines across multiple therapeutic areas. The company is led by a team of experienced scientists and executives with a track record of creating approved drugs and founding successful biotech companies.
2 investors
K18 develops biotechnology-based hair care products designed to repair and strengthen hair for consumers. The company's patented molecular technology targets hair damage across all hair types through both professional salon and at-home product lines.
2 investors
Kadance provides insurance-based precision health programs and clinical navigation services focused on addressing health inequities through genomics-informed care. The company serves insurers and their members, particularly in oncology care and cancer survivorship management.
2 investors
Kanaphterapeutics is a pharmaceutical company developing synthetic drugs and antibody-based therapeutics for cancer treatment using proprietary human genome analysis and ADC (antibody-drug conjugate) technologies.
2 investors
Kangstem Biotech is a South Korean biotechnology company developing stem cell-based therapeutics for rare and intractable diseases, including its FURESTEM-OA product for osteoarthritis. It also operates a CDMO (contract development and manufacturing) business and conducts related R&D.
2 investors
Kardigan develops targeted cardiovascular treatments through a discovery and translational research platform, with a pipeline of late-stage drug candidates aimed at functional cures for cardiovascular disease. The company integrates AI and real-world data to advance clinical development across multiple underserved cardiovascular conditions.
2 investors